Nevertheless, the potential contribution of NKG2D-expressing CD4+ T cells or helper T cell subpopulation depletion, or other tumor microenvironment factors to the suppression of CD8+ T cell function in B16F10-ULBP2 tumors cannot be ruled out and warrants further investigation. This evidence concerns the gene CD4 and neoplasm.